Tagawa M - Search Results

1

[Long-term treatment for non-A, non-B chronic hepatitis--effects on hepatitis C virus (HCV)].

Omata M, Tada M, Hosoda K, Takano S, Tagawa M, Imazeki F, Yokosuka O, Ito Y, Ohto M. Omata M, et al. Among authors: tagawa m. Nihon Shokakibyo Gakkai Zasshi. 1990 Jun;87(6):1430-5. Nihon Shokakibyo Gakkai Zasshi. 1990. PMID: 2120488 Japanese.

2

Spontaneous negativation of serum hepatitis C virus RNA is a rare event in type C chronic liver diseases: analysis of HCV RNA in 320 patients who were followed for more than 3 years.

Yokosuka O, Kojima H, Imazeki F, Tagawa M, Saisho H, Tamatsukuri S, Omata M. Yokosuka O, et al. Among authors: tagawa m. J Hepatol. 1999 Sep;31(3):394-9. doi: 10.1016/s0168-8278(99)80028-2. J Hepatol. 1999. PMID: 10488695 Clinical Trial.

3

Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.

Omata M, Ito Y, Yokosuka O, Imazeki F, Tagawa M, Takano S, Hosoda K, Tada M, Ohto M, Ito K, et al. Omata M, et al. Among authors: tagawa m. Dig Dis Sci. 1991 Sep;36(9):1217-22. doi: 10.1007/BF01307512. Dig Dis Sci. 1991. PMID: 1654240 Clinical Trial.

4

Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients.

Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Takano S, et al. Among authors: tagawa m. Hepatology. 1995 Mar;21(3):650-5. Hepatology. 1995. PMID: 7875662

5

Infection of human hepatocyte cell lines with hepatitis C virus in vitro.

Tagawa M, Kato N, Yokosuka O, Ishikawa T, Ohto M, Omata M. Tagawa M, et al. J Gastroenterol Hepatol. 1995 Sep-Oct;10(5):523-7. doi: 10.1111/j.1440-1746.1995.tb01341.x. J Gastroenterol Hepatol. 1995. PMID: 8963027

6

GB virus-C RNA in Japanese patients with hepatocellular carcinoma and cirrhosis.

Kanda T, Yokosuka O, Imazeki F, Tagawa M, Ehata T, Saisho H, Omata M. Kanda T, et al. Among authors: tagawa m. J Hepatol. 1997 Sep;27(3):464-9. doi: 10.1016/s0168-8278(97)80349-2. J Hepatol. 1997. PMID: 9314122

7

Etiologic considerations of fulminant non-A, non-B viral hepatitis in Japan: analyses by nucleic acid amplification method.

Fukai K, Yokosuka O, Fujiwara K, Tagawa M, Imazeki F, Saisho H, Omata M. Fukai K, et al. Among authors: tagawa m. J Infect Dis. 1998 Aug;178(2):325-33. doi: 10.1086/515619. J Infect Dis. 1998. PMID: 9697711

8

Quantitative analysis of GBV-C RNA in liver and serum by strand-specific reverse transcription-polymerase chain reaction.

Kanda T, Yokosuka O, Tagawa M, Kawai S, Imazeki F, Saisho H. Kanda T, et al. Among authors: tagawa m. J Hepatol. 1998 Nov;29(5):707-14. doi: 10.1016/s0168-8278(98)80250-x. J Hepatol. 1998. PMID: 9833907

9

Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: comparison with mutations in precore and core regions in relation to clinical status.

Honda A, Yokosuka O, Ehata T, Tagawa M, Imazeki F, Saisho H. Honda A, et al. Among authors: tagawa m. J Med Virol. 1999 Apr;57(4):337-44. J Med Virol. 1999. PMID: 10089043

10

Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients.

Seta T, Yokosuka O, Imazeki F, Tagawa M, Saisho H. Seta T, et al. Among authors: tagawa m. J Med Virol. 2000 Jan;60(1):8-16. doi: 10.1002/(sici)1096-9071(200001)60:1<8::aid-jmv2>3.0.co;2-u. J Med Virol. 2000. PMID: 10568756

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

778 results

Search Page

Filters